Tilray Brands (TLRY) Equity Average (2018 - 2026)
Tilray Brands (TLRY) reported Equity Average of $1.5 billion for Q1 2026, down 50.09% on a YoY basis from $3.1 billion in Q1 2025, and little changed quarter-over-quarter from $1.5 billion in Q4 2025.
Tilray Brands (TLRY) Equity Average (2018 - 2026) Analysis & Trends
Tilray Brands has reported Equity Average for 9 years, with the latest figure at $1.5 billion in Q1 2026.
- For the quarter ending Q1 2026, Equity Average fell 50.09% year-over-year to $1.5 billion; the trailing twelve-month figure through Feb 2026 stood at $1.5 billion (down 50.09% YoY), and the FY2025 full-year result was $2.5 billion, down 27.17% from the prior year.
- Equity Average for Q1 2026 stood at $1.5 billion, roughly flat from $1.5 billion in the prior quarter.
- The five-year high for Equity Average was $4.6 billion in Q1 2022, with the low at $1.5 billion in Q3 2025.
- Historically, Equity Average has averaged $3.3 billion across 5 years, with a median of $3.4 billion in 2024.
- Annual changes were most pronounced in 2022 — Equity Average jumped 274.0% — and 2025, when it slumped 56.54%.
- Tilray Brands' Equity Average stood at $4.5 billion in 2022, then declined by 24.89% to $3.4 billion in 2023, then climbed by 2.09% to $3.5 billion in 2024, then tumbled by 55.79% to $1.5 billion in 2025, then rose by 0.16% to $1.5 billion in 2026.
- The last three Equity Average figures came in at $1.5 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.5 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 493.55 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.15 Bn |
| 10 | Tilray Brands | - | - | 54.95 Mn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 1.54 Bn |
| Nov 30, 2025 | 1.53 Bn |
| Aug 31, 2025 | 1.51 Bn |
| May 31, 2025 | 2.10 Bn |
| Feb 28, 2025 | 3.08 Bn |
| Nov 30, 2024 | 3.47 Bn |
| Aug 31, 2024 | 3.46 Bn |
| May 31, 2024 | 3.39 Bn |
| Feb 29, 2024 | 3.37 Bn |
| Nov 30, 2023 | 3.40 Bn |
| Aug 31, 2023 | 3.37 Bn |
| May 31, 2023 | 3.37 Bn |
| Feb 28, 2023 | 3.94 Bn |
| Nov 30, 2022 | 4.52 Bn |
| Aug 31, 2022 | 4.50 Bn |
| May 31, 2022 | 4.55 Bn |
| Feb 28, 2022 | 4.57 Bn |
| Nov 30, 2021 | 4.43 Bn |
| Aug 31, 2021 | 4.43 Bn |
| May 31, 2021 | 2.78 Bn |